02-11-2017 дата публикации
Номер: US20170311603A1
Принадлежит:
The invention relates to the use of bismuth subsalicylate or one of the derivatives thereof as a phytopharmaceutical agent, in particular for the treatment or prevention of fungal diseases in plants. 118-. (canceled)20. The method of claim 19 , wherein:{'sub': 1', '3, 'Rand Rare —H,'}{'sub': 2', '4, 'Rand Rare independently selected from —H, —Cl and —F,'}X and Y are O,M is Cu or Bi, and{'sub': 1', '6', '2', '2', 'n', '2', '2, 'L is H, a C-Chydroxyalkyl, or —(CH—CH—O)—CH—CH—OH where n is an integer ranging from 1 to 19.'}22. The method of claim 19 , wherein the fungal disease develops in a wood part of the plant.23. The method of claim 19 , wherein the fungal disease develops in the trunk claim 19 , the root and/or the stem of the plant.24. The method of claim 19 , wherein the plant is a grapevine.25. The method of claim 19 , wherein the fungal disease is a grapevine trunk disease.26EutypaBotryosphaeria. The method of claim 25 , wherein the fungal disease is selected from the group consisting of esca claim 25 , dieback claim 25 , dieback claim 25 , black dead aim claim 25 , black rot claim 25 , and dead-arm disease.27EutypaPhaeomoniellaPhaeoacremoniumFormitoporiaVerticilliumStereumPhomopsis.. The method of claim 19 , wherein the fungal disease develops in a wood part of the plant and is associated with one or several pathogens selected from the group consisting of pathogens belonging to the family Botryosphaeriaceae claim 19 , pathogens belonging to the genus claim 19 , pathogens belonging to the genus claim 19 , pathogens belonging to the genus claim 19 , pathogens belonging to the genus claim 19 , pathogens belonging to the genus claim 19 , pathogens belonging to the genus and pathogens belonging to the genus28Phaeomoniella chlamydospora, Phaeoacremonium aleophilum, Eutypa lata, Fomitiporia mediterranea, Fomitiporia punctata, Botryosphaeria stevensii, Diplodia seriata, Neofusicoccum parvum, Stereum hirsutumVerticillium longisporum.. The method of claim 27 , wherein ...
Подробнее